Latest News in the pharma Industry

Research & Development

ADDC and AstraZeneca announce third year of screening partnership

ADDC and AstraZeneca announce third year of screening partnership

10 Aug 2016

Partnership facilitates efforts by researchers from academia to discover novel compounds with the potential to become new patient treatments.

Read more 
Veritas reaches important scientific milestone

Veritas reaches important scientific milestone

10 Aug 2016

Animal studies fully underway to evaluate the safety and effectiveness of cannabis strains.

Read more 
University of Pittsburgh licenses novel microneedle patch to SkinJect

University of Pittsburgh licenses novel microneedle patch to SkinJect

9 Aug 2016

SkinJect Microneedle Patch to deliver drug to treat and immunize skin cancer patients.

Read more 
Charles River Laboratories announces partnership with the Milner Therapeutics Institute and Consortium

Charles River Laboratories announces partnership with the Milner Therapeutics Institute and Consortium

9 Aug 2016

Through this partnership, the academic institutions in the Consortium will have access to Charles River’s early discovery and drug development resources and services to accelerate their early-stage drug development processes.

Read more 
FDA approves Merck’s Keytruda for patients with recurrent or metastatic HNSCC

FDA approves Merck’s Keytruda for patients with recurrent or metastatic HNSCC

7 Aug 2016

New treatment option for patients with with disease progression on or after platinum-containing chemotherapy.

Read more 
BMS CheckMate -26 trial fails to meet primary endpoint

BMS CheckMate -26 trial fails to meet primary endpoint

7 Aug 2016

Opdivo did not meet trial primary endpoint of progression-free survival in patients expressing PD-L1 ≥ 5%.

Read more 
Regeneron and Adicet Bio collaborate to discover and develop next-generation engineered immune cell therapeutics

Regeneron and Adicet Bio collaborate to discover and develop next-generation engineered immune cell therapeutics

3 Aug 2016

Companies to pursue "off-the-shelf" cellular therapies in oncology.

Read more 
Catalent Biologics and Zumutor collaborate to develop antibodies with enhanced ADCC Activity

Catalent Biologics and Zumutor collaborate to develop antibodies with enhanced ADCC Activity

2 Aug 2016

The partnership created a fucose knockout GPEx cell line expressing high levels of an anti-HER2 antibody.

Read more 
Selecta Biosciences describes novel approach for improving the efficacy and safety profile of biologic drugs

Selecta Biosciences describes novel approach for improving the efficacy and safety profile of biologic drugs

1 Aug 2016

The data support Selecta’s lead clinical program, showing Selecta’s SVP-Rapamycin (SEL-110) induces antigen-specific immune tolerance and prevents the formation of anti-drug antibodies to biologic drugs, including pegsiticase (for gout) and adalimumab ...

Read more 
EMA accepts for review the Marketing Authorisation Application for sarilumab

EMA accepts for review the Marketing Authorisation Application for sarilumab

1 Aug 2016

Sarilumab is an investigational human monoclonal antibody directed against the IL-6 receptor that is intended for the treatment of adult patients with moderately to severely active rheumatoid arthritis.

Read more 
Sunovion submits NDA for SUN-101/eFlow to FDA for the treatment of patients with COPD

Sunovion submits NDA for SUN-101/eFlow to FDA for the treatment of patients with COPD

31 Jul 2016

If approved, SUN-101/eFlow will be the first nebulized long-acting muscarinic antagonist (LAMA) for the long-term, maintenance treatment of airflow obstruction in patients with COPD.

Read more 
NIH-led researchers develop software that could facilitate drug development

NIH-led researchers develop software that could facilitate drug development

29 Jul 2016

AptaTRACE is the first algorithm that uses the full scope of sequencing data from a large number of selection rounds to capture sequence and structure features of aptamers that bind to the target.

Read more